Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
Tags:
Clinical Products Politics

Two strengths of ranitidine among 22 price concessions for November

  • News

The Department of Health and Social Care (DH) and the National Assembly for Wales have agreed concessionary prices for the following 22 items for November 2019 prescriptions.

An initial nine price concessions for the month were announced on November 19.

Drug
Strength
Form
Price
Amiloride
5mg
tablets (28)
£19.50
Bumetanide
1mg
tablets (28)
£1.95
Co-careldopa
25mg/100mg
tablets (100)
£11.99
Dexamfetamine
5mg/5ml
sugar-free oral solution (500)
£381.63
Indapamide
2.5mg
tablets (28)
£2.20
Irbesartan
75mg
tablets (28)
£3.44
Irbesartan
150mg
tablets (28)
£6.33
Irbesartan
300mg
tablets (28)
£6.93
Levetiracetam
1g
tablets (60)
£12.50
Meloxicam
15mg
tablets (30)
£5.55
Memantine
10mg
tablets (28)
£3.30
Nefopam
30mg
tablets (90)
£7.99
Nifedipine
5mg
capsules (90)
£51.95
Nifedipine
10mg
capsules (90)
£65.63
Nitrofurantoin
100mg
tablets (28)
£10.68
Nizatidine
150mg
capsules (30)
£7.99
Oxytetracycline
250mg
tablets (28)
£4.99
Propranolol
10mg
tablets (28)
£2.00
Propranolol
40mg
tablets (28)
£2.00
Quinine sulfate
300mg
tablets (28)
£5.90
Ranitidine
150mg
tablets (60)
£4.07
Ranitidine
300mg
tablets (30)
£3.85

Certain batches of ranitidine-containing medicines have been subject to recall and quarantine, as the Medicines and Healthcare products Regulatory Agency (MHRA) investigates their potential contamination with N-nitrosodimethylamine (NDMA), which is a known risk factor for some cancers. 

Last week (November 19), the MHRA announced the latest ranitidine-containing products to be recalled: Creo Pharma Limited's ranitidine oral solution 30mg/ml and Tillomed Laboratories Limited's ranitidine 150mg tablets.

Table

View full table

Do these prices reflect the ones you have paid in November so far?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Tags:
Clinical Products Politics
Latest News & Analysis

Electronic prescription service ‘approved’ for rollout across Wales

‘New normal’ of medicine shortages a ‘significant burden on pharmacists’

Covert surveillance: GPhC may abandon ‘never used’ spying powers

Extra £9m cash injection for growing Glasgow digital pharmacy Phlo

See All
UsernamePublicRestriction

Register

CD006215

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By